Stem cells and clinical trials: the current status and future perspectives

Dong-Wook Kim

doi:10.5124/jkma.2011.54.5.448

J Korean Med Assoc > Volume 54(5); 2011 > Article

Kim: Stem cells and clinical trials: the current status and future perspectives

Focused Issue of This Month

Stem Cells

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2011; 54(5): 448-449.

Published online: May 11, 2011

DOI: https://doi.org/10.5124/jkma.2011.54.5.448

Stem cells and clinical trials: the current status and future perspectives

Dong-Wook Kim, PhD^1,^2,³

¹Department of Physiology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

²Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

³Stem Cell Research Center, Seoul, Korea.

Corresponding author: Dong-Wook Kim, dwkim2@yuhs.ac

Received April 21, 2011 Accepted April 28, 2011

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145–1147.

2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.